Subtitles are available in English and other languages. They are automatically generated using AI, so some errors may occur.

Is DCB a new valid option for coronary revascularisation?

Stents, scaffolds and DCB
Hotline / Late-Breaking Trials
Room 242AB

Anchorperson: Robert Byrne

Spokesperson: Ran Kornowski

Discussants: Michael Joner, Bruno Scheller, Giulio Stefanini, Ron Waksman

Paclitaxel vs sirolimus-coated balloons for CAD: 2-year follow-up of two large registries

Bernardo Cortese

Discussion and audience interaction
Clinical outcomes of bailout stenting after Drug-Coated Balloon angioplasty

Mauro Gitto

Discussion and audience interaction
DEB vs DES for the treatment of large native coronary artery disease: an updated meta-analysis

Jose A. Sorolla Romero

Discussion and audience interaction
Head-to-head comparison of Limus vs Paclitaxel DCBs in the Treatment of In-Stent Restenosis

Marios Sagris

Discussion and audience interaction
Optimal Treatment for Coronary Drug-eluting Stent In-stent Restenosis

Peter Kulyassa

Discussion and audience interaction

Suggested videos